The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice
Open accessAbstract
Background: Alzheimer's disease is a complex neurodegenerative disorder characterized pathologically by a temporal and spatial progression of beta-amyloid (Aβ) deposition, neurofibrillary tangle formation, and synaptic degeneration. Inflammatory processes have been implicated in initiating and/or propagating AD-associated pathology within the brain, as inflammatory cytokine expression and other markers of inflammation are pronounced in individuals with AD pathology. The current study examines whether inflammatory processes are evident early in the disease process in the 3xTg-AD mouse model and if regional differences in inflammatory profiles exist. Methods: Coronal brain sections were used to identify Aβ in 2, 3, and 6-month 3xTg-AD and non-transgenic control mice. Quantitative real-time RT-PCR was performed on microdissected entorhinal cortex and hippocampus tissue of 2, 3, and 6-month 3xTg-AD and non-transgenic mice. Microglial/macrophage cell numbers were quantified using unbiased stereology in 3xTg-AD and non-transgenic entorhinal cortex and hippocampus containing sections. Results: We observed human Aβ deposition at 3 months in 3xTg-AD mice which is enhanced by 6 months of age. Interestingly, we observed a 14.8-fold up-regulation of TNF-α and 10.8-fold up-regulation of MCP-1 in the entorhinal cortex of 3xTg-AD mice but no change was detected over time in the hippocampus or in either region of non-transgenic mice. Additionally, this increase correlated with a specific increase in F4/80-positive microglia and macrophages in 3xTg-AD entorhinal cortex. Conclusion: Our data provide evidence for early induction of inflammatory processes in a model that develops amyloid and neurofibrillary tangle pathology. Additionally, our results link inflammatory processes within the entorhinal cortex, which represents one of the earliest AD-affected brain regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similar to previous findings in AD brains and mouse models, 39 -42 the levels of CCL2 and TNF␣ mRNAs were elevated in the APPPS1;Cx3cr1 ϩ/ϩ mouse brain.”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citationStaging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Moreover, individuals diagnosed with mild cognitive impairment, a forme fruste of AD, display decreased entorhinal and hippocampal volume, primarily associated with diminished neuron number as compared to non-cognitively impaired controls [7-10].”
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Cited by
Sorted by citations
Items 101–200 of 261
Zheng, Y., Zhang, X., Zhang, R., Wang, Z., Gan, J., Gao, Q., Yang, L., Xu, P., & Jiang, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5314 · Cited by 52
Zhang, W., Bai, M., Ye, X., Hao, J., Zhang, Z., Su, C., Lei, G., Miao, J., & Li, Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.023 · Cited by 53
RetractedSynergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 52
CCR6: A Biomarker for Alzheimer's-like Disease in a Triple Transgenic Mouse Model
Subramanian, S., Ayala, P., Wadsworth, T. L., Harris, C., Vandenbark, A. A., Quinn, J. F., & Offner, H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100852 · Cited by 50
Zhao, Y., Qian, R., Zhang, J., Liu, F., Iqbal, K., Dai, C., & Gong, C. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00639-w · Cited by 55
Manno, F. A. M., Isla, A. G., Manno, S. H. C., Ahmed, I., Cheng, S. H., Barrios, F. A., & Lau, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00039 · Cited by 49
Anti-TNF Antibodies: Lessons from the Past, Roadmap for the Future
Shealy, D. J., & Visvanathan, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_5 · Cited by 49
Bronzuoli, M. R., Facchinetti, R., Valenza, M., Cassano, T., Steardo, L., & Scuderi, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00644 · Cited by 48
Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research
Yang, H., Zeng, F., Luo, Y., Zheng, C., Ran, C., & Yang, J. (2022) · Molecules · doi:10.3390/molecules27123879 · Cited by 52
Buoso, E., Masi, M., Limosani, R. V., Oliviero, C., Saeed, S., Iulini, M., Passoni, F. C., Racchi, M., & Corsini, E. (2025) · Journal of Xenobiotics · doi:10.3390/jox15010013 · Cited by 51
Treatment with a γ-Ketoaldehyde Scavenger Prevents Working Memory Deficits in hApoE4 Mice
Davies, S. S., Bodine, C. L., Matafonova, E., Pantazides, B. G., Bernoud‐Hubac, N., Harrison, F. E., Olson, S. J., Montine, T. J., Amarnath, V., & Roberts, L. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102118 · Cited by 46
L-Norvaline, a new therapeutic agent against Alzheimer’s disease
Polis, B., Srikanth, K. D., Gurevich, V., Gil-Henn, H., & Samson, A. O. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255980 · Cited by 50
Frazer, M. E., Hughes, J. E., Mastrangelo, M. A., Tibbens, J. L., Federoff, H. J., & Bowers, W. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.39 · Cited by 47
Self-citationBalietti, M., Giorgetti, B., Casoli, T., Solazzi, M., Tamagnini, F., Burattini, C., Aicardi, G., & Fattoretti, P. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121711 · Cited by 50
Ren, D., Fu, Y., Wang, L., Liu, J., Zhong, X., Yuan, J., Jiang, C., Wang, H., & Li, Z. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153627 · Cited by 45
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease
Zeng, J., Liao, Z., Yang, H., Wang, Q., Wu, Z., Hua, F., & Zhou, Z. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106461 · Cited by 53
Sudol, K. L., Mastrangelo, M. A., Narrow, W. C., Frazer, M. E., Levites, Y., Golde, T. E., Federoff, H. J., & Bowers, W. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.174 · Cited by 50
Self-citationBrandi, E., Torres-Garcia, L., Svanbergsson, A., Haikal, C., Liu, D., Li, W., & Li, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.910988 · Cited by 48
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 45
Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
Montacute, R., Foley, K., Forman, R., Else, K. J., Cruickshank, S. M., & Allan, S. M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0826-5 · Cited by 43
Griffith, C. M., Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X., Reagan, L. P., Strader, A. D., Rose, G. M., & Patrylo, P. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180707 · Cited by 44
Fagan, S. G., Béchet, S., & Dev, K. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02613-5 · Cited by 41
Inflammation: A Major Target for Compounds to Control Alzheimer’s Disease
Maccioni, R. B., Navarrete, L. P., González, A., González-Canacer, A., Guzmán‐Martínez, L., & Cortés, N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191014 · Cited by 42
Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease
Yu, D., Corbett, B. F., Yan, Y., Zhang, G., Reinhart, P. H., Cho, S. J., & Chin, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.023 · Cited by 39
Rodriguez, J. J., Noristani, H. N., & Verkhratsky, A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0693-5 · Cited by 38
Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
Luca, A., Calandra, C., & Luca, M. (2018) · Aging and Disease · doi:10.14336/ad.2018.0201 · Cited by 42
Eufemi, M., Cocchiola, R., Romaniello, D., Correani, V., Di Francesco, L., Fabrizi, C., Maras, B., & Schininà, M. E. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.01.007 · Cited by 39
Mazzitelli, S., Filipello, F., Rasile, M., Lauranzano, E., Cucuzza, C. S., Tamborini, M., Pozzi, D., Barajon, I., Toni Giorgino, A., Natalello, A., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0381-9 · Cited by 38
Rodriguez, J. J., Noristani, H. N., Hilditch, T., Olabarria, M., Yeh, C., Witton, J., & Verkhratsky, A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.036 · Cited by 38
Microglia in Alzheimer's Disease: A Role for Ion Channels
Thei, L., Imm, J. L., Kaisis, E., Dallas, M. L., & Kerrigan, T. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00676 · Cited by 37
Glia Maturation Factor Expression in Entorhinal Cortex of Alzheimer’s Disease Brain
Thangavel, R., Kempuraj, D., Stolmeier, D. A., Anantharam, P., Khan, M. M., & Zaheer, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1080-6 · Cited by 35
Kamal, M. A., Priyamvada, S., Anbazhagan, A. N., Jabir, N. R., Tabrez, S. S. M., & Greig, N. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660137 · Cited by 37
Ma, Y., Ma, B., Shang, Y., Yin, Q., Yan, H., Xu, S., Shen, C., Hou, X., & Liu, X. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.001 · Cited by 34
Pena, G. S., Paez, H. G., Johnson, T. K., Halle, J. L., Carzoli, J. P., Visavadiya, N. P., Zourdos, M. C., WHITEHURST, M. A., & Khamoui, A. V. (2020) · International Journal of Chronic Diseases · doi:10.1155/2020/5919501 · Cited by 38
Tobinick, E. L. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015073 · Cited by 34
Neuroimaging of mouse models of Alzheimer’s disease
Jullienne, A., Trinh, M. V., & Obenaus, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020305 · Cited by 32
Yi, B., Jahangir, A. M., Evans, A. K., Briggs, D. I., Rāviņa, K., Ernest, J. P., Farimani, A. B., Sun, W., Rajadas, J., Green, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180319 · Cited by 33
Patel, J. R., & Brewer, G. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21663 · Cited by 32
Regulation of cyclic AMP response element‐binding protein during neuroglial interactions
Qin, L., Bouchard, R. J., & Pugazhenthi, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13497 · Cited by 31
Innate immunity in Alzheimer’s disease: the relevance of animal models?
Franco-Bocanegra, D., Nicoll, J. A. R., & Boche, D. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1729-4 · Cited by 32
Cytokines in CNS Inflammation and Disease
Tansey, M. G., & Wyss‐Coray, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_5 · Cited by 32
Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice
Kapadia, M., Mian, M. F., Michalski, B., Azam, A. B., Ma, D., Salwierz, P., Christopher, A., Rosa, E., Zovkic, I. B., Forsythe, P., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170779 · Cited by 29
Haskins, M., Jones, T. E., Lu, Q., & Bareiss, S. K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.002 · Cited by 29
In Vitro and In Vivo Neuroprotective Effects of Sarcosine
Tanas, A., Tozlu, Ö. Ö., Gezmiş, T., Hacımüftüoğlu, A., El‐Aty, A. M. A., Ceylan, O., Mardinoğlu, A., & Türkez, H. (2022) · BioMed Research International · doi:10.1155/2022/5467498 · Cited by 29
Tobinick, E. L. (2008) · PubMed · Cited by 28
Wang, C., Shen, D., Hu, Y., Chen, J., Liu, J., Huang, Y., Yu, X., Chu, H., Zhang, C., Yin, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054805 · Cited by 26
Cavanagh, C., & Wong, T. P. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.01.003 · Cited by 28
Weber, G. E., Koenig, K. A., Khrestian, M., Shao, Y. Y., Tuason, E. D., Gramm, M., Lal, D., Leverenz, J. B., & Bekris, L. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901166 · Cited by 27
Stuart, K. E., King, A. E., King, N. E., Collins, J. M., Vickers, J. C., & Ziebell, J. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.015 · Cited by 27
Xu, H., Bhaskaran, S., Piekarz, K. M., Ranjit, R., Bian, J., Kneis, P., Ellis, A., Bhandari, S., Rice, H. C., & Remmen, H. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.876816 · Cited by 25
(2011) · Europe PMC (PubMed Central) · Cited by 25
Apolipoprotein CI Knock-Out Mice Display Impaired Memory Functions
Berbée, J. F. P., Vanmierlo, T., Abildayeva, K., Blokland, A., Jansen, P. J., Lütjohann, D., Gautier, T., Sijbrands, E., Prickaerts, J., Hadfoune, M., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100576 · Cited by 25
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 25
Differential roles of regulatory T cells in Alzheimer's disease
Jafarzadeh, A., Sheikhi, A., Jafarzadeh, Z., & Nemati, M. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104778 · Cited by 26
β-amyloid and glutamate receptors
Gasparini, L., & Dityatev, A. E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.005 · Cited by 24
Tumor Necrosis Factor-α-mediated Regulation of the Inositol 1,4,5-Trisphosphate Receptor Promoter
Park, K. M., Yule, D. I., & Bowers, W. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034504 · Cited by 24
Self-citationSabogal-Guáqueta, A. M., Carrillo-Hormaza, L., Osorio, E., & Cardona‐Gómez, G. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.002 · Cited by 24
Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders
Rossi, D., Martorana, F., & Brambilla, L. (2011) · CNS Drugs · doi:10.2165/11593090-000000000-00000 · Cited by 24
N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
Layé, S., Madore, C., St‐Amour, I., Delpech, J.-C., Joffre, C., Nadjar, A., & Calon, F. (2015) · Nutrition and Aging · doi:10.3233/nua-150049 · Cited by 24
Güell‐Bosch, J., Lope‐Piedrafita, S., Esquerda‐Canals, G., Montoliu‐Gaya, L., & Villegas, S. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4263 · Cited by 21
Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson’s disease
Lin, W., Chou, K., Lee, P., Huang, Y., Tsai, N., Chen, H.-L., Cheng, K., Wang, H., Lin, T., Li, S.-H., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0749-9 · Cited by 22
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 22
Byrnes, S. J., Eddine, J. J., Zhou, J., Chalmers, E. K., Wanicek, E., Osman, N., Jenkins, T. A., Roche, M., Brew, B. J., Estes, J. D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1570692 · Cited by 22
Peña‐Ortega, F. (2019) · Current Alzheimer Research · doi:10.2174/1567205017666191213162233 · Cited by 21
Cassel, J., Mathis, C., Majchrzak, M. J., Moreau, P., & Dalrymple‐Alford, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000135615 · Cited by 21
Genetic Therapies for Alzheimer’s Disease: A Scoping Review
Lennon, M. J., Rigney, G., Raymont, V., & Sachdev, P. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215145 · Cited by 23
Reprint of: Microglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 19
Fu, L., Jiang, G., Weng, H., Dick, G. M., Chang, Y.-Z., & Kassab, G. S. (2019) · Brain Pathology · doi:10.1111/bpa.12759 · Cited by 20
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
Dionisio-Santos, D. A., Behrouzi, A., Olschowka, J. A., & O’Banion, M. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00441 · Cited by 20
Tian, M., Shen, J., Qi, Z., Feng, Y., & Fang, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201142 · Cited by 19
Vicente, M. C., Paneghini, J. D. L., Stabile, A. M., Amorim, M. R., Silva, C. E. A., Patrone, L. G. A., Cunha, T. M., Bícego, K. C., Almeida, M. C., Carrettiero, D. C., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230151 · Cited by 21
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05008-x · Cited by 19
Kalovyrna, N., Apokotou, O., Boulekou, S., Paouri, E., Boutou, A., & Georgopoulos, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65378-2 · Cited by 16
Pérez-Martín, E., Pérez-Revuelta, L., Barahona-López, C., Pérez-Boyero, D., Alonso, J. R., Díaz, D., & Weruaga, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119691 · Cited by 16
Impaired TNF-α Control of IP3R-mediated Ca2+ Release in Alzheimer's Disease Mouse Neurons
Park, K. M., Yule, D., & Bowers, W. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.006 · Cited by 16
Self-citationLöffler, T., Flunkert, S., Havas, D., Schweinzer, C., Uger, M. D., Windisch, M., Steyrer, E., & Hutter‐Paier, B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-84 · Cited by 15
Altered circadian behavior and light sensing in mouse models of Alzheimer’s disease
Weigel, T. K., Guo, C. L., Güler, A. D., & Ferris, H. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1218193 · Cited by 15
Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00745-9 · Cited by 14
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 14
Fernandes, A. M. A., Caldeira, C., Cunha, C., Ferreiro, E. B., Vaz, A. R., & Brites, D. M. T. O. (2022) · Cells · doi:10.3390/cells11010137 · Cited by 14
Liu, W., Chen, S., Rao, X., Yang, Y., Chen, X., & Yu, L. (2023) · Biomedicines · doi:10.3390/biomedicines11010194 · Cited by 14
Cavanagh, C., Colby-Milley, J., Farso, M. C., Krantic, S. M., & Quirion, R. (2011) · Future Neurology · doi:10.2217/fnl.11.50 · Cited by 15
Microglia-Mediated Aβ Propagation in Alzheimer’s Disease
Yang, L., Feng, S., Wu, C., & Yang, L. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00907-9 · Cited by 11
Entorhinal vessel density correlates with phosphorylated tau and TDP‐43 pathology
Rodríguez, J. L., van der Kouwe, A. J. W., Oltmer, J., Rosenblum, E. W., Mercaldo, N. D., Fischl, B. R., Marshall, M., Frosch, M. P., & Augustinack, J. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13896 · Cited by 10
CHCHD10S59L/+ mouse model: Behavioral and neuropathological features of frontotemporal dementia
Genin, E. C., di Borgo, P. P., Lorivel, T., Hugues, S., Farinelli, M., Mauri-Crouzet, A., Lespinasse, F., Godin, L., Paquis‐Flucklinger, V., & Petit-Paitel, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106498 · Cited by 9
Microglia energy metabolism: A new perspective on Alzheimer's disease treatment
Wu, Q.-L., Yang, X., Luo, J.-X., Liu, L., Zhou, Y., & Lu, M. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123585 · Cited by 12
Cell ageing: a flourishing field for neurodegenerative diseases
Brites, D. M. T. O. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.225 · Cited by 10
Farso, M. C., Krantic, S. M., Rubio, M., Sarfati, M., & Quirion, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.053 · Cited by 9
The 3xTg-AD Mouse Model: A Comprehensive Tool for Understanding Alzheimer’s Disease
Pattanayak, A., & Firdous, S. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01655-w · Cited by 13
Fernandez, F., Aust, C. E., Lye, S., & Griffiths, L. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100435 · Cited by 8
McLarnon, J. G. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191106095038 · Cited by 8
Kang, E. Y., Kim, D., Kim, H. K., Shin, W., Park, Y., Kim, T. H., Kim, W., Cao, L., Lee, S. G., Gang, G., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300329 · Cited by 8
Chemoattractants and receptors in Alzheimer s disease
Le, Y. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s81 · Cited by 7
Lin, N., Goh, A., Lin, S., Chuang, K., Chang, C.-H., Li, M., Lu, C.-H., Chen, W., Wei, P.-H., Pan, I.-H., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220056 · Cited by 6
Falangola, M. F., Dhiman, S., Voltin, J. R., & Jensen, J. H. (2023) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2023.06.017 · Cited by 6
Future Treatment of Alzheimer Disease
Keskin, A. O., Durmaz, N., Uncu, G., Erzurumluoglu, E., Yıldırım, Z., Tuncer, N., & Adapınar, D. Ö. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85096 · Cited by 6
Baeta-Corral, R., la Fuente, M. D., & Giménez‐Llort, L. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114189 · Cited by 7
Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases
Sastre, M., Katsouri, L., Birch, A. M., Renziehausen, A., Dexter, D. T., Crichton, R. R., & Ward, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch6 · Cited by 6
The Role of Inflammation in Amyloid Diseases
Azevedo, E. P., & Foguel, D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81888 · Cited by 7
Identification of molecular compounds critical to Alzheimer's‐like plaque formation
Gellermann, G. P., Ullrich, K., Unger, C., Fändrich, M., Sauter, S. R. N., & Diekmann, S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21311 · Cited by 5
Metadata
- Authors
- Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J.
- Affiliations
- University of Rochester Medicine (US)
- University of California, Irvine (US)
- Corresponding author
- Bowers, William J
- Venue
- Journal of Neuroinflammation
- Published
- 2005-10-18
- Volume
- 2
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC1276812
- OpenAlex
- W2163115168
- Cited by
- 260
- References
- 41
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 22 · 2023: 13 · 2022: 13 · 2021: 8 · 2020: 18 · 2019: 13 · 2018: 14 · 2017: 14 · 2016: 12 · 2015: 18 · 2014: 11 · 2013: 13 · 2012: 15
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG020204, R01AG023593)
- National Institute of Neurological Disorders and Stroke (F31NS049995)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microglial activation, neuroinflammation, 3xTg-AD mice, entorhinal cortex, hippocampus, amyloid-beta deposition, TNF-α, MCP-1, microglia/macrophages, F4/80, neurofibrillary tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review